Phase I trial of RG7116 in patients with solid tumours
Latest Information Update: 27 Apr 2012
At a glance
- Drugs Lumretuzumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 27 Apr 2012 New trial record
Latest Information Update: 27 Apr 2012